Matrix metalloproteinase-3 gene polymorphisms are associated with ischemic stroke

Journal of Interferon and Cytokine Research

Volumn 32, Issue 2, 2012, Pages 81-86

  Kim, Su Kang ^a   Kang, Sung Wook ^a   Kim, Dong Hwan ^a   Yun, Dong Hwan ^a   Chung, Joo Ho ^a   Ban, Ju Yeon ^b  

^a Kyung Hee University Hospital   (South Korea)

^b BK21 Plus NBM Global Research Center for Regenerative Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

STROMELYSIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; HAPLOTYPES; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; SEX CHARACTERISTICS; SEX FACTORS; STROKE;

EID: 84863059070     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0022     Document Type: Article

References (25)

1. Berger K, Stogbauer F, Stoll M, Wellmann J, Huge A, Cheng S, Kessler C, John U, Assmann G, Ringelstein EB, Funke H. 2007. The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case-control studies. Hum Genet 121(2):169-178. (Pubitemid 46404451)
2. Bersano A, Ballabio E, Bresolin N, Candelise L. 2008. Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat 29(6):776-795. (Pubitemid 351794129)
3. Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. 2003. Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 41(12):2130-2137. (Pubitemid 36724257)
4. Cunningham LA, Wetzel M, Rosenberg GA. 2005. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50(4):329-339. (Pubitemid 40780839)
5. Dominiczak AF, McBride MW. 2003. Genetics of common polygenic stroke. Nat Genet 35(2):116-117. (Pubitemid 37187626)
6. Fatar M, Stroick M, Griebe M, Hennerici M. 2005. Matrix metalloproteinases in cerebrovascular diseases. Cerebrovasc Dis 20(3):141-151. (Pubitemid 41254175)
7. Fatar M, Stroick M, Steffens M, Senn E, Reuter B, Bukow S, Griebe M, Alonso A, Lichtner P, Bugert P, Meitinger T, Wienker TF, Hennerici MG. 2008. Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes. Cerebrovasc Dis 26(2):113-119.
8. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, Tondi P, Pola P, Pola R. 2004. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35(10):2270-2275. (Pubitemid 39311248)
9. Gunel M, Lifton RP. 1996. Counting strokes. Nat Genet 13(4): 384-385. (Pubitemid 26256605)
10. Kaplan RC, Smith NL, Zucker S, Heckbert SR, Rice K, Psaty BM. 2008. Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis 201(1):130-137.
11. Keith VA, Mansbach RS, Geyer MA. 1991. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30(6):557-566.
12. Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, Matsushita T, Yamazaki K, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Sueishi K, Iida M, Nakamura Y, Kiyohara Y. 2007. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 39(2):212-217. (Pubitemid 46184352)
13. Lim TW, Kim SK, Ban JY, Chung J-H, Song JY, Yoon KL, Park SW, Kim KS, Shin OY. 2009. Polymorphisms of transmembrane channel-like 1 gene are associated with Kawasaki disease in Korean population. Mol Cell Toxicol 5(4):291-297.
14. Lo EH, Wang X, Cuzner ML. 2002. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69(1): 1-9. (Pubitemid 34734159)
15. Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, Ferro JM, Oliveira SA, Vicente AM. 2010. Variants of the matrix metalloproteinase-2 but not the matrix metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 11:40.
16. Matarin M, Brown WM, Dena H, Britton A, De Vrieze FW, Brott TG, Brown RD, Jr., Worrall BB, Case LD, Chanock SJ, Metter EJ, Ferruci L, Gamble D, Hardy JA, Rich SS, Singleton A, Meschia JF. 2009. Candidate gene polymorphisms for ischemic stroke. Stroke 40(11):3436-3442.
17. Mun-Bryce S, Rosenberg GA. 1998. Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab 18(11): 1163-1172. (Pubitemid 28509829)
18. Nagase H, Woessner JF, Jr. 1999. Matrix metalloproteinases. J Biol Chem 274(31):21491-21494.
19. Natoli AK, Medley TL, Ahimastos AA, Drew BG, Thearle DJ, Dilley RJ, Kingwell BA. 2005. Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension 46(5): 1129-1134. (Pubitemid 41533015)
20. Park SY, Kim MH, Kang SY, Suh JT, Lee WI. 2007. Inflammatory marker expression and its implication in Korean ischemic stroke patients. Korean J Lab Med 27(3):197-204.
21. Reuter B, Bugert P, Stroick M, Bukow S, Griebe M, Hennerici MG, Fatar M. 2009. TIMP-2 gene polymorphism is associated with intracerebral hemorrhage. Cerebrovasc Dis 28(6): 558-563.
22. Rosenberg GA, Navratil M. 1997. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48(4):921-926.
23. Slowik A, Turaj W, Dziedzic T, Haefele A, Pera J, Malecki MT, Glodzik-Sobanska L, Szermer P, Figlewicz DA, Szczudlik A. 2004. DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology 63(2):359-361. (Pubitemid 38971144)
24. Wang X, Mori T, Jung JC, Fini ME, Lo EH. 2002. Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma 19(5):615-625. (Pubitemid 34587304)
25. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. 2008. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 359(18): 1897-1908.